EA200200314A1 - Олигосахаридные производные рибоза-рибит-фосфата и содержащие их вакцины - Google Patents

Олигосахаридные производные рибоза-рибит-фосфата и содержащие их вакцины

Info

Publication number
EA200200314A1
EA200200314A1 EA200200314A EA200200314A EA200200314A1 EA 200200314 A1 EA200200314 A1 EA 200200314A1 EA 200200314 A EA200200314 A EA 200200314A EA 200200314 A EA200200314 A EA 200200314A EA 200200314 A1 EA200200314 A1 EA 200200314A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mixtures
oligosaccharides
vaccines
ribose
phosphate
Prior art date
Application number
EA200200314A
Other languages
English (en)
Other versions
EA005381B1 (ru
Inventor
Висенте Гильермо Верес Бенкомо
Рене Рой
Original Assignee
Универсидад Де Ла Хабана
Юниверсити Оф Оттава
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Универсидад Де Ла Хабана, Юниверсити Оф Оттава filed Critical Универсидад Де Ла Хабана
Publication of EA200200314A1 publication Critical patent/EA200200314A1/ru
Publication of EA005381B1 publication Critical patent/EA005381B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08Polyoxyalkylene derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

Настоящее изобретение относится к области медицины, в частности, к химическим синтезам смесей олигосахаридов, полученных из рибоза-рибит-фосфата, используемых в качестве активной основы в вакцинах для профилактики инфекций, вызываемых Haemophilus influenzae типа b (Hib), а также касается вакцин, содержащих указанные смеси олигосахаридов. Смеси олигосахаридов, полученные химическим синтезом по настоящему изобретению, включают повторяющиеся звенья формулы (фосфат-рибоза-рибит)n или (рибоза-рибит-фосфат)n, по меньшей мере, из 5 соединений структур А или В, представляющих повторяющееся звено капсульного полисахарида Haemophilus Influenzae типа b и отличающихся только величиной n, при этом n принимает значения в интервале от 4 до 25 и где Rили Rозначает спейсер для конъюгации с носителем, при условии, что R=спейсер, если R=H, или R=спейсер, если R=H. Изобретение касается также иммуногенов, содержащих указанные смеси олигосахаридов, вакцин, содержащих указанные иммуногены, и способов получения указанных олигосахаридов в виде смесей. Кроме того, настоящее изобретение включает использование вакцин отдельно либо в сочетании с другими вакцинами для профилактики инфекций, вызываемых Haemophilus Influenzae типа b.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200314A 1999-08-30 2000-08-15 Олигосахаридные производные рибоза-рибит-фосфата и содержащие их вакцины EA005381B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1999121A CU22904A1 (es) 1999-08-30 1999-08-30 Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
PCT/CU2000/000003 WO2001016146A1 (es) 1999-08-30 2000-08-15 Oligosacáridos derivados de ribosa-ribitol-fosfato y vacunas que los contienen

Publications (2)

Publication Number Publication Date
EA200200314A1 true EA200200314A1 (ru) 2002-10-31
EA005381B1 EA005381B1 (ru) 2005-02-24

Family

ID=5459405

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200314A EA005381B1 (ru) 1999-08-30 2000-08-15 Олигосахаридные производные рибоза-рибит-фосфата и содержащие их вакцины

Country Status (24)

Country Link
US (1) US6765091B1 (ru)
EP (1) EP1212334B1 (ru)
JP (1) JP4850377B2 (ru)
KR (1) KR100818163B1 (ru)
CN (1) CN1205217C (ru)
AR (1) AR025435A1 (ru)
AT (1) ATE308551T1 (ru)
AU (1) AU780816B2 (ru)
BR (1) BRPI0013686B8 (ru)
CA (1) CA2382602C (ru)
CO (1) CO5180646A1 (ru)
CU (1) CU22904A1 (ru)
CZ (1) CZ2002721A3 (ru)
DE (1) DE60023722T2 (ru)
DK (1) DK1212334T3 (ru)
EA (1) EA005381B1 (ru)
ES (1) ES2252045T3 (ru)
HK (1) HK1050693A1 (ru)
MX (1) MXPA02002066A (ru)
NZ (1) NZ517464A (ru)
SI (1) SI1212334T1 (ru)
UA (1) UA75579C2 (ru)
WO (1) WO2001016146A1 (ru)
ZA (1) ZA200201667B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005209303A1 (en) * 2004-01-29 2005-08-11 Biosynexus, Inc. Use of amino-oxy functional groups in the preparation of vaccines conjugates
WO2011017101A2 (en) 2009-07-27 2011-02-10 Fina Biosolutions, Llc Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
BR112012002230A2 (pt) 2009-07-31 2020-08-18 National Research Council Canada epítopo do núcleo externo do lipopolissacarídeo do h. pylori.
SG181750A1 (en) 2009-12-17 2012-07-30 Fina Biosolutions Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
NZ602971A (en) * 2010-04-23 2014-11-28 Serum Inst India Ltd Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
CN109843899B (zh) 2016-07-28 2022-04-19 马克斯·普朗克科学促进学会 用作对流感嗜血杆菌b型的疫苗的稳定耐水解的合成的聚核糖基核糖醇磷酸衍生物
EP3768309A4 (en) * 2018-03-23 2021-12-01 Koranex Capital PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae

Also Published As

Publication number Publication date
UA75579C2 (en) 2006-05-15
DE60023722D1 (de) 2005-12-08
KR20020068501A (ko) 2002-08-27
CN1376158A (zh) 2002-10-23
DE60023722T2 (de) 2006-07-20
BRPI0013686B1 (pt) 2016-07-26
EP1212334B1 (en) 2005-11-02
CA2382602C (en) 2010-02-16
AU780816B2 (en) 2005-04-21
CZ2002721A3 (cs) 2002-07-17
SI1212334T1 (sl) 2006-04-30
BRPI0013686B8 (pt) 2021-05-25
EP1212334A1 (en) 2002-06-12
HK1050693A1 (en) 2003-07-04
KR100818163B1 (ko) 2008-03-31
US6765091B1 (en) 2004-07-20
AU6817300A (en) 2001-03-26
NZ517464A (en) 2004-03-26
AR025435A1 (es) 2002-11-27
CU22904A1 (es) 2004-01-23
MXPA02002066A (es) 2004-07-30
ES2252045T3 (es) 2006-05-16
ATE308551T1 (de) 2005-11-15
EA005381B1 (ru) 2005-02-24
DK1212334T3 (da) 2006-03-20
ZA200201667B (en) 2003-08-27
JP2003528032A (ja) 2003-09-24
CN1205217C (zh) 2005-06-08
CA2382602A1 (en) 2001-03-08
BR0013686A (pt) 2002-08-13
JP4850377B2 (ja) 2012-01-11
CO5180646A1 (es) 2002-07-30
WO2001016146A1 (es) 2001-03-08

Similar Documents

Publication Publication Date Title
ATE409048T1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
TW221811B (ru)
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
WO1990004918A3 (en) Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
FI884626A (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
FR2385693A1 (fr) Derives d'acetamide utiles notamment en therapeutique
EA200100983A1 (ru) Производные 13-метилэритромицина
CA2336412A1 (en) Medicament for treatment of diabetes
KR950014067A (ko) 아릴아미드유도체
EA199900135A1 (ru) Производные пиразолопиридина и их применение в качестве фармацевтического препарата
EA200200314A1 (ru) Олигосахаридные производные рибоза-рибит-фосфата и содержащие их вакцины
FR2636625B1 (fr) Benzylamines disubstituees, leur procede de preparation, leur utilisation comme medicament et leurs intermediaires de synthese
FI944823A0 (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
AP9801377A0 (en) Tricyclic erythromycin derivatives.
AR002741A1 (es) Benciloxicarbonilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico asi como medicamentoque las contiene
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
EA200201024A1 (ru) Фармацевтические композиции, содержащие олигосахариды, и их получение
WO2002055491A3 (en) 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
DE69030052D1 (de) Lösliche, nichttoxische Derivate von basischen Polyenmakroliden, ihre Herstellung und Verwendung
DK0677051T3 (da) Derivater af benzoylecgonin, ecgonin og ecgonidin som lægemidler
EA199700287A1 (ru) Бензамиды для лечения нейродегенеративных заболеваний
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
EA199900156A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU